OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
OXM-104, a potential candidate for the treatment of obesity, NASH and type 2 diabetes
Simone Anna Melander, Ashref Kayed, Kim Vietz Andreassen, et al.
European Journal of Pharmacology (2023) Vol. 962, pp. 176215-176215
Open Access | Times Cited: 6
Simone Anna Melander, Ashref Kayed, Kim Vietz Andreassen, et al.
European Journal of Pharmacology (2023) Vol. 962, pp. 176215-176215
Open Access | Times Cited: 6
Showing 6 citing articles:
GLP-1 receptor agonists in the treatment of diabetic non–alcoholic steatohepatitis patients
Ernest Adeghate
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 3, pp. 223-232
Open Access | Times Cited: 5
Ernest Adeghate
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 3, pp. 223-232
Open Access | Times Cited: 5
Ponatinib alleviates non-alcoholic steatohepatitis through TFEB-mediated autophagy
Zhuomiao Lin, Meiqing Yang, Xin Yu, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Zhuomiao Lin, Meiqing Yang, Xin Yu, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
The role of gut–islet axis in pancreatic islet function and glucose homeostasis
Qi Chen, Yuanyuan Gao, Fangyu Li, et al.
Diabetes Obesity and Metabolism (2025)
Open Access
Qi Chen, Yuanyuan Gao, Fangyu Li, et al.
Diabetes Obesity and Metabolism (2025)
Open Access
Nicotinate-curcumin improves NASH by inhibiting the AKR1B10/ACCα-mediated triglyceride synthesis
Xiu-Lian Lin, Yaling Zeng, Jie Ning, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Xiu-Lian Lin, Yaling Zeng, Jie Ning, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Efficacy and Safety of GLP-1 Receptor Agonists in Patients with MASLD: A Systematic Review and Meta-analysis of Randomized Clinical Trials
Basile Njei, Yazan A. Al‐Ajlouni, Samira Yaya Lemos, et al.
Authorea (Authorea) (2024)
Open Access
Basile Njei, Yazan A. Al‐Ajlouni, Samira Yaya Lemos, et al.
Authorea (Authorea) (2024)
Open Access
Efficacy and Safety of GLP-1 Receptor Agonists in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Basile Njei, Yazan A. Al‐Ajlouni, Samira Yaya Lemos, et al.
Cureus (2024)
Open Access
Basile Njei, Yazan A. Al‐Ajlouni, Samira Yaya Lemos, et al.
Cureus (2024)
Open Access
